Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Trading update & equity funding facility proposal

2 Apr 2024 07:00

RNS Number : 9011I
Insig AI Plc
02 April 2024
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this information is considered to be in the public domain.

 

Insig AI plc

("Insig AI" or the "Company")

Trading update and equity funding facility proposal

Trading update

Group revenue (unaudited) for its financial year ended 31 March 2024 ("FY-24") is expected to be approximately £1.3 million comprising approximately £0.4 million from the Insig AI business and approximately £0.9 million from the legacy Sport in Schools business which was sold in November 2023.

Frustratingly, this revenue from the Insig AI business is considerably lower than our previously communicated target of not less than £1.4 million, and also does not recognise the progress on certain material contracts and relationships, which the Board remain optimistic will be secured in short order. In particular, two licence contracts, with a combined sales value of £1.0 million, did not close prior to the year end. Whilst there can be no guarantee that these contracts will be secured, they are each at a very advanced stage.

 

Trials with two of the "Big 4" Accounting Practices

The Company's repository of 220,000 corporate reports, including AI machine learning, search engine and CHAT GPT capabilities is currently being trialled by two of the "Big 4" Accounting Practices. To date, feedback from both practices has been positive, and we are hopeful one of these could transition to a formal collaboration or similar, over the coming months.

Equity funding facility proposal

The delayed commercialisation of certain key pipeline opportunities, has resulted in working capital of the Group becoming constrained. Accordingly, the board is considering a £250,000 equity funding facility proposal from Richard Bernstein, Executive Chairman of Insig AI. The proposal is to subscribe for up to 1,250,000 new ordinary shares at 20p a share. This represents a premium of 17.6% to the closing share price of 17 pence on 28 March 2024. Funds would be used for general working capital purposes, as well as for investment into sales and marketing. Should the parties enter into this equity facility, this would be deemed to be an AIM Rule 13 'Related Party Transaction'.

Richard Bernstein, Insig AI Chairman commented: "We have several important proposals with strong prospects of converting into sales, with our machine learning corporate reporting database attracting significant interest from major consultancies, including two of the "Big 4" Accounting Practices. During this period of focus on converting these prospects into revenues, I am happy to provide equity funding at a significant premium to the current share price, to provide the team further time to realise these opportunities."

 

For further information, please visit www.insg.ai or contact:

 

 

Insig AI plc

Richard Bernstein

Colm McVeigh, CEO 

richard.bernstein@insg.ai

colin.mcveigh@insg.ai 

 

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold 

+44 (0) 203 829 5000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUASRRSKUSRUR
Date   Source Headline
1st Jun 20267:00 amRNSEquity subscription raising £0.2m and TVR
30th Apr 20267:00 amRNSNon-executive Directors’ Remuneration in Shares
22nd Apr 20267:00 amRNSEquity Subscription, TVR and PDMR Dealing
20th Apr 20267:00 amRNS-RCentral Bank MCP server in action
13th Apr 20267:00 amRNS-RLaunch of Central Bank Model Context Protocol
7th Apr 20267:01 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSPDMR Dealings
1st Apr 20267:00 amRNSTrading update and potential NASDAQ listing
3rd Mar 20267:00 amRNSInsig AI contract win and revenue share agreement
28th Jan 20267:00 amRNSGrant of Share Options
28th Jan 20267:00 amRNSPDMR Dealing
27th Jan 20267:00 amRNSPDMR Dealing
11th Dec 20257:00 amRNSDirector Dealings
9th Dec 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSNew contract with global advisory firm
29th Oct 20257:00 amRNS-RNew client win: new vertical market breakthrough
27th Oct 20257:00 amRNS-RMelloLondon Investor Event
16th Oct 20253:51 pmRNSResult of AGM
16th Oct 20257:00 amRNSTrading update & extended CLNs and warrant terms
8th Oct 202511:43 amRNSEquity fundraise
7th Oct 20257:00 amRNSEquity fundraise
1st Oct 20257:00 amRNSAppointment of Digital Asset Adviser
22nd Sep 20257:00 amRNSSubscription, Director Dealing & TVR
19th Sep 20257:00 amRNSFinal Results, Posting of AR&A and Notice of AGM
30th Jul 20257:00 amRNS-RLaunch of New Website and Corporate Brand Update
24th Jul 20257:00 amRNSDirector Dealing and Total Voting Rights
3rd Jul 20257:00 amRNSAppointment - Strategic & Asset Allocation Adviser
24th Jun 20257:05 amRNS-RAppointment of Business Development Director
24th Jun 20257:00 amRNSEquity Funding, Subscription, TVR & PDMR Dealing
6th Jun 20257:00 amRNSPDMR Dealings
20th May 20257:00 amRNS-RNew client win and additional sales prospects
12th May 20257:00 amRNS-RMello2025 Investor Event
8th May 20257:00 amRNS-RStrategic client win and new GIE product launch
6th May 20258:00 amRNS-RInsig AI & Falcon Windsor publish research re FTSE
29th Apr 20257:00 amRNSTrading Update and New Client Win
15th Apr 20257:00 amRNSPDMR Dealings
27th Mar 20257:00 amRNSPDMR Dealings
26th Mar 20257:00 amRNSPDMR Dealings
25th Mar 20257:00 amRNSPDMR Dealings
24th Mar 20257:03 amRNSTransfer of Share Options
24th Mar 20257:00 amRNSTrading Update, Equity Subscription, Funding & TVR
13th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20259:21 amRNSReplacement: Change of website address
3rd Mar 20257:00 amRNSChange of website address
17th Feb 20257:00 amRNSNew Client Win and Revenue Share Partnership
19th Dec 20247:00 amRNSInterim Results
22nd Nov 20247:00 amRNSNew business win
11th Oct 20247:00 amRNSDirector Dealing
2nd Oct 202411:14 amRNSPDMR Dealing
30th Sep 20242:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.